CHECKPOINT THERAPEUTICS INC (CKPT) Stock Analyst Earnings Estimates
NASDAQ:CKPT - Nasdaq - US1628282063 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 270K -74.77% | 190K -29.63% | 103K -45.79% | 13.943K -86.46% | 41.936M 300,658.78% | 189.43M 351.71% | 933.21M 392.64% | 391.38M -58.06% | 491.14M 25.49% | 596.98M 21.55% | 706.9M 18.41% | 864M 22.22% | |
| EBITDA YoY % growth | N/A -87.78% | N/A -22.19% | N/A -62.71% | -39.066M 43.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -56.72M -144.48% | -58.33M -2.84% | -52.148M 10.60% | -37.007M 29.03% | -5.802M 84.32% | 100.6M 1,833.96% | 714.23M 609.97% | 272.99M -61.78% | 373.46M 36.80% | 462.98M 23.97% | 591.02M 27.66% | 731.66M 23.80% | |
| Operating Margin | -21,007.41% | -30,700.00% | -50,629.13% | -265,410.90% | -13.83% | 53.11% | 76.53% | 69.75% | 76.04% | 77.55% | 83.61% | 84.68% | |
| EPS YoY % growth | -7.40 -80.49% | -7.09 4.19% | -3.33 53.03% | -0.93 72.13% | -0.17 81.87% | 0.94 657.58% | 6.11 551.09% | 2.16 -64.61% | 2.72 25.94% | 3.14 15.36% | 3.72 18.51% | 4.55 22.19% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 82.38% | -0.19 41.27% | -0.03 83.00% | 0.30 228.61% | 0.27 236.84% |
| Revenue Q2Q % growth | -100.00% | 7.429M 18,019.51% | 29.714M | 34.617M | |
| EBITDA Q2Q % growth | -11.118M 36.26% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.078M 10.73% | -8.167M 25.40% | -1.433M 78.52% | 16.427M 268.93% | 15.496M 270.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.23 20.69% | -0.15 | -0.08 | -53.74% |
| Q2 2024 Q2Q % growth | -0.18 82.86% | -0.31 | 0.13 | 42.14% |
| Q1 2024 Q2Q % growth | -0.33 62.92% | -0.28 | -0.05 | -18.37% |
| Q4 2023 Q2Q % growth | -1.10 51.97% | -0.55 | -0.55 | -98.49% |
| Q3 2023 Q2Q % growth | -0.29 75.83% | -0.78 | 0.49 | 62.59% |
| Q2 2023 Q2Q % growth | -1.05 34.38% | -0.80 | -0.25 | -31.98% |
| Q1 2023 Q2Q % growth | -0.89 55.50% | -1.09 | 0.20 | 18.20% |
| Q4 2022 Q2Q % growth | -2.29 41.28% | -1.33 | -0.96 | -71.91% |
| Q3 2022 Q2Q % growth | -1.20 14.29% | -1.50 | 0.30 | 19.79% |
| Q2 2022 Q2Q % growth | -1.60 -33.33% | -1.76 | 0.16 | 9.07% |
| Q1 2022 Q2Q % growth | -2.00 -122.22% | -1.45 | -0.55 | -38.08% |
| Q4 2021 Q2Q % growth | -3.90 -129.41% | -1.57 | -2.33 | -148.28% |
| Q3 2021 Q2Q % growth | -1.40 -55.56% | -1.39 | -0.01 | -0.92% |
| Q2 2021 Q2Q % growth | -1.20 -33.33% | -1.06 | -0.14 | -13.12% |
| Q1 2021 Q2Q % growth | -0.90 -50.00% | -1.07 | 0.17 | 15.97% |
| Q4 2020 Q2Q % growth | -1.70 22.73% | -0.82 | -0.88 | -108.33% |
| Q3 2020 Q2Q % growth | -0.90 40.00% | -0.82 | -0.08 | -10.29% |
| Q2 2020 Q2Q % growth | -0.90 40.00% | -0.92 | 0.02 | 1.96% |
| Q1 2020 Q2Q % growth | -0.60 66.67% | -1.29 | 0.69 | 53.56% |
| Q4 2019 Q2Q % growth | -2.20 | -1.70 | -0.50 | -29.41% |
| Q3 2019 Q2Q % growth | -1.50 | -1.70 | 0.20 | 11.77% |
| Q2 2019 Q2Q % growth | -1.50 | -1.73 | 0.23 | 13.49% |
| Q1 2019 Q2Q % growth | -1.80 | -2.75 | 0.95 | 34.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 10.537K | -10.537K | -100.00% |
| Q2 2024 Q2Q % growth | 41K 32.26% | 15.81K | 25.19K | 159.33% |
| Q1 2024 Q2Q % growth | -100.00% | 10.2K | -10.2K | -100.00% |
| Q4 2023 Q2Q % growth | 6K -91.43% | 22.95K | -16.95K | -73.86% |
| Q3 2023 Q2Q % growth | 31K -38.00% | 12.75K | 18.25K | 143.14% |
| Q2 2023 Q2Q % growth | 31K 55.00% | 5.1K | 25.9K | 507.84% |
| Q1 2023 Q2Q % growth | 35K -30.00% | 17.003K | 17.997K | 105.84% |
| Q4 2022 Q2Q % growth | 70K 250.00% | 32.64K | 37.36K | 114.46% |
| Q3 2022 Q2Q % growth | 50K 66.67% | 50K | % | |
| Q2 2022 Q2Q % growth | 20K -87.50% | 20K | % | |
| Q1 2022 Q2Q % growth | 50K -28.57% | 17.85K | 32.15K | 180.11% |
| Q4 2021 Q2Q % growth | 20K -33.33% | 71.4K | -51.4K | -71.99% |
| Q3 2021 Q2Q % growth | 30K | 122.4K | -92.4K | -75.49% |
| Q2 2021 Q2Q % growth | 160K 300.00% | 116.28K | 43.72K | 37.60% |
| Q1 2021 Q2Q % growth | 70K -92.78% | 145.35K | -75.35K | -51.84% |
| Q4 2020 Q2Q % growth | 30K | 112.2K | -82.2K | -73.26% |
| Q3 2020 Q2Q % growth | 30K -89.29% | 197.197K | -167.197K | -84.79% |
| Q2 2020 Q2Q % growth | 40K -96.19% | 401.197K | -361.197K | -90.03% |
| Q1 2020 Q2Q % growth | 970K 177.14% | 588.203K | 381.797K | 64.91% |
| Q4 2019 Q2Q % growth | 30K | 408K | -378K | -92.65% |
| Q3 2019 Q2Q % growth | 280K | 578.003K | -298.003K | -51.56% |
| Q2 2019 Q2Q % growth | 1.05M | 754.8K | 295.2K | 39.11% |
| Q1 2019 Q2Q % growth | 350K | 1.203M | -853K | -70.91% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.55% | 35.96% | -3.41% | -16.17% |
| Revenue | -100% | -100% | -43.04% | -60.18% |